Hai Pan Linlin Zhang Fanlu Meng Shasha Guan Diansheng Zhong
10.3389/fonc.2023.1159308
Front Oncol
2023 May 12;13:1159308.
egfr v774m/l833v almonertinib compound mutation lung adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/37251951/
Case Reports
PMC10213279
37251951
EGFR p.V774M/p.L833V compound mutations in lung adenocarcinoma responded well to almonertinib: a case report
2023